Literature DB >> 8693972

Functional MR in the evaluation of dementia: correlation of abnormal dynamic cerebral blood volume measurements with changes in cerebral metabolism on positron emission tomography with fludeoxyglucose F 18.

R G González1, A J Fischman, A R Guimaraes, C A Carr, C E Stern, E F Halpern, J H Growdon, B R Rosen.   

Abstract

PURPOSE: To determine whether magnetic susceptibility functional MR imaging of cerebral blood volumes provides information similar to fludeoxyglucose F 18 positron emission tomography (PET) brain images in patients undergoing evaluation for dementia.
METHODS: Ten subjects were studied with both PET and functional MR. Clinical diagnoses included probable Alzheimer disease (n = 5), possible Alzheimer disease (n = 1), Pick disease (n = 2), and primary progressive aphasia (n = 2). The studies were quantitatively evaluated by coregistration of PET and functional MR images followed by regression analyses of corresponding regions of interest. Qualitatively, each brain was categorized into eight regions, and each was classified as normal or abnormal by visual inspection.
RESULTS: Correlation coefficients between registered functional MR and PET images were excellent (mean, r = 0.58) in most of the cerebrum. Significant correlations were observed in 72 of 74 brain sections. Qualitatively, 16 brain regions were judged to be abnormal by both MR imaging and PET; 46 regions were normal by both; 10 regions were abnormal by PET only; and 8 regions were abnormal only by functional MR. The concordance between functional MR and PET was 78%, which was highly significant.
CONCLUSION: Cerebral blood volumes images derived from magnetic susceptibility (functional MR) provide information similar to fludeoxyglucose F 18 PET images in demented patients undergoing evaluation for dementia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8693972      PMCID: PMC8338228     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  38 in total

Review 1.  Imaging Alzheimer's disease.

Authors:  Scott A Small
Journal:  Curr Neurol Neurosci Rep       Date:  2003-09       Impact factor: 5.081

2.  Imaging correlates of brain function in monkeys and rats isolates a hippocampal subregion differentially vulnerable to aging.

Authors:  Scott A Small; Monica K Chawla; Michael Buonocore; Peter R Rapp; Carol A Barnes
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-26       Impact factor: 11.205

3.  Multivariate and univariate analysis of continuous arterial spin labeling perfusion MRI in Alzheimer's disease.

Authors:  Iris Asllani; Christian Habeck; Nikolaos Scarmeas; Ajna Borogovac; Truman R Brown; Yaakov Stern
Journal:  J Cereb Blood Flow Metab       Date:  2007-10-24       Impact factor: 6.200

4.  Type III neuregulin-1 is required for normal sensorimotor gating, memory-related behaviors, and corticostriatal circuit components.

Authors:  Ying-Jiun J Chen; Madeleine A Johnson; Michael D Lieberman; Rose E Goodchild; Scott Schobel; Nicole Lewandowski; Gorazd Rosoklija; Ruei-Che Liu; Jay A Gingrich; Scott Small; Holly Moore; Andrew J Dwork; David A Talmage; Lorna W Role
Journal:  J Neurosci       Date:  2008-07-02       Impact factor: 6.167

5.  T1rho MRI of Alzheimer's disease.

Authors:  Arijitt Borthakur; Matthew Sochor; Christos Davatzikos; John Q Trojanowski; Christopher M Clark
Journal:  Neuroimage       Date:  2008-04-01       Impact factor: 6.556

6.  Linking hippocampal structure and function to memory performance in an aging population.

Authors:  Christiane Reitz; Adam M Brickman; Truman R Brown; Jennifer Manly; Charles DeCarli; Scott A Small; Richard Mayeux
Journal:  Arch Neurol       Date:  2009-11

7.  A summary risk score for the prediction of Alzheimer disease in elderly persons.

Authors:  Christiane Reitz; Ming-Xin Tang; Nicole Schupf; Jennifer J Manly; Richard Mayeux; José A Luchsinger
Journal:  Arch Neurol       Date:  2010-07

8.  Regional vulnerability in Huntington's disease: fMRI-guided molecular analysis in patients and a mouse model of disease.

Authors:  Nicole M Lewandowski; Yvette Bordelon; Adam M Brickman; Sergio Angulo; Usman Khan; Jordan Muraskin; Erica Y Griffith; Paula Wasserman; Liliana Menalled; Jean Paul Vonsattel; Karen Marder; Scott A Small; Herman Moreno
Journal:  Neurobiol Dis       Date:  2012-12-04       Impact factor: 5.996

9.  Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver.

Authors:  Scott A Schobel; Nashid H Chaudhury; Usman A Khan; Beatriz Paniagua; Martin A Styner; Iris Asllani; Benjamin P Inbar; Cheryl M Corcoran; Jeffrey A Lieberman; Holly Moore; Scott A Small
Journal:  Neuron       Date:  2013-04-10       Impact factor: 17.173

10.  Cerebral blood volume in Alzheimer's disease and correlation with tissue structural integrity.

Authors:  Jinsoo Uh; Kelly Lewis-Amezcua; Kristin Martin-Cook; Yamei Cheng; Myron Weiner; Ramon Diaz-Arrastia; Michael Devous; Dinggang Shen; Hanzhang Lu
Journal:  Neurobiol Aging       Date:  2009-02-05       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.